Suppr超能文献

致癌性表皮生长因子/ Ras 信号和 Ets 转录因子对结直肠癌细胞中 microRNA-21 表达的调控。

Control of MicroRNA-21 expression in colorectal cancer cells by oncogenic epidermal growth factor/Ras signaling and Ets transcription factors.

机构信息

Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

出版信息

DNA Cell Biol. 2012 Aug;31(8):1403-11. doi: 10.1089/dna.2011.1469. Epub 2012 May 3.

Abstract

MicroRNAs (miRs) are important regulators of gene expression in normal physiology and disease, and are widely misexpressed in cancer. A number of studies have identified miR-21 as an important promoter of oncogenesis. However, as is true of most miRs, the mechanisms behind the aberrant expression of miR-21 in cancer are poorly understood. Herein, we examine the regulation of miR-21 expression in colorectal cancer (CRC) cells by the oncogenic epidermal growth factor (EGF)/Ras pathway and by Ets transcription factors, modulators of epithelial oncogenesis that are frequently misexpressed in CRC. We show that EGF/Ras efficiently induces the miR-21 primary transcript, but this does not rapidly and simply translate into higher mature miR-21 levels. Rather, induction of mature miR-21 by constitutive activation of this pathway is slow, is associated with only minimal activation of mitogen-activated protein kinase, and may involve stimulation of post-transcriptional processing by mechanisms other than Dicer stabilization. We further identify Ets transcription factors as modifiers of miR-21 expression in CRC. The effects of Ets factors on miR-21 expression are cell context-dependent, and appear to involve both direct and indirect mechanisms. The Ets factor Pea3 emerges from our studies as a consistent repressor of miR-21 transcription. Overall, our studies identify a complex relationship between oncogenic pathways and steady-state miR-21 levels in CRC, and highlight the need for greater understanding of the control of miR expression in cancer and other disease states.

摘要

微小 RNA(miRs)是正常生理和疾病中基因表达的重要调节因子,并且在癌症中广泛表达异常。许多研究已经确定 miR-21 是致癌作用的重要促进剂。然而,与大多数 miRs 一样,miR-21 在癌症中异常表达的机制还了解甚少。在此,我们通过致癌性表皮生长因子(EGF)/Ras 途径和 Ets 转录因子检查了结直肠癌(CRC)细胞中 miR-21 表达的调节,EGF/Ras 途径和 Ets 转录因子是上皮癌发生的调节剂,在 CRC 中经常表达异常。我们表明 EGF/Ras 能有效地诱导 miR-21 的初级转录物,但这不会迅速而简单地转化为更高水平的成熟 miR-21。相反,该途径的组成性激活诱导成熟 miR-21 的速度较慢,与丝裂原活化蛋白激酶的最小激活相关,并且可能涉及通过 Dicer 稳定以外的机制刺激转录后加工。我们进一步确定 Ets 转录因子是 CRC 中 miR-21 表达的调节剂。Ets 因子对 miR-21 表达的影响取决于细胞的上下文,并且似乎涉及直接和间接机制。Ets 因子 Pea3 从我们的研究中脱颖而出,是 miR-21 转录的一致抑制剂。总体而言,我们的研究确定了致癌途径与 CRC 中稳态 miR-21 水平之间的复杂关系,并强调需要更深入地了解癌症和其他疾病状态下 miR 表达的控制。

相似文献

7
A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs.
Oncogene. 2011 Dec 8;30(49):4910-20. doi: 10.1038/onc.2011.197. Epub 2011 Jun 6.
10
MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer.
Oncogene. 2013 Apr 11;32(15):1910-20. doi: 10.1038/onc.2012.214. Epub 2012 Jun 18.

引用本文的文献

1
An update on the molecular mechanisms underlying the progression of miR-21 in oral cancer.
World J Surg Oncol. 2025 Mar 1;23(1):73. doi: 10.1186/s12957-025-03732-2.
3
MicroRNA-766-3p-mediated downregulation of HNF4G inhibits proliferation in colorectal cancer cells through the PI3K/AKT pathway.
Cancer Gene Ther. 2022 Jun;29(6):803-813. doi: 10.1038/s41417-021-00362-0. Epub 2021 Jun 22.
5
P21 is not a prognostic marker for rectal cancer - five-year follow up study of rectal cancer in stages I-IV.
Contemp Oncol (Pozn). 2020;24(4):247-251. doi: 10.5114/wo.2020.102632. Epub 2021 Jan 4.
6
Pluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells.
Int J Nanomedicine. 2016 Oct 3;11:4991-5002. doi: 10.2147/IJN.S114302. eCollection 2016.
7
MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1.
Onco Targets Ther. 2016 Mar 7;9:1231-9. doi: 10.2147/OTT.S99228. eCollection 2016.
8
miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
Mol Cancer. 2015 May 1;14:98. doi: 10.1186/s12943-015-0372-7.
9
MiR-21/RASA1 axis affects malignancy of colon cancer cells via RAS pathways.
World J Gastroenterol. 2015 Feb 7;21(5):1488-97. doi: 10.3748/wjg.v21.i5.1488.
10
Human mesenchymal stem cells suppress the stretch-induced inflammatory miR-155 and cytokines in bronchial epithelial cells.
PLoS One. 2013 Aug 13;8(8):e71342. doi: 10.1371/journal.pone.0071342. eCollection 2013.

本文引用的文献

1
A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs.
Oncogene. 2011 Dec 8;30(49):4910-20. doi: 10.1038/onc.2011.197. Epub 2011 Jun 6.
2
Upregulation of miR-21 by Ras in vivo and its role in tumor growth.
Oncogene. 2011 Jan 20;30(3):275-86. doi: 10.1038/onc.2010.416. Epub 2010 Oct 18.
3
Regression of murine lung tumors by the let-7 microRNA.
Oncogene. 2010 Mar 18;29(11):1580-7. doi: 10.1038/onc.2009.445. Epub 2009 Dec 7.
4
MicroRNAs as potential cancer therapeutics.
Oncogene. 2008 Dec;27 Suppl 2(Suppl 2):S52-7. doi: 10.1038/onc.2009.353.
6
Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling.
Cell. 2009 Oct 2;139(1):112-22. doi: 10.1016/j.cell.2009.06.044.
7
Regulation of MicroRNA Biogenesis: A miRiad of mechanisms.
Cell Commun Signal. 2009 Aug 10;7:18. doi: 10.1186/1478-811X-7-18.
8
miR-21 as a key regulator of oncogenic processes.
Biochem Soc Trans. 2009 Aug;37(Pt 4):918-25. doi: 10.1042/BST0370918.
9
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12085-90. doi: 10.1073/pnas.0905234106. Epub 2009 Jul 13.
10
Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell.
RNA. 2009 Aug;15(8):1443-61. doi: 10.1261/rna.1534709. Epub 2009 Jun 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验